ODTX insider buying and SEC filings, explained
Odyssey Therapeutics, Inc. · CIK 1882782
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$30.1M
Insiders who bought
4
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 11, 2026 | Other purchase | James G. Coulter (Former 10% Owner) bought 1,388,889 Common Stock indirectly at $18.00 ($25.0M) in a public offering. Indirect holdings up 60% to 3,690,146 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed May 13, 2026 |
| May 8, 2026 | Purchase (code P) | Dimension Capital II, L.P. (Director) bought 1,111,111 shares at $18.00 ($20.0M), reported as a purchase (code P). Holdings up 50% to 3,333,516 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 12, 2026 |
| May 11, 2026 | Purchase (code P) | Simeon George (10% owner) bought 555,555 shares indirectly at $18.00 ($10.0M), reported as a purchase (code P). Indirect holdings up 14% to 1,831,383 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed May 11, 2026 |
| May 11, 2026 | Other purchase | Nan (LN) Li (Director) bought 1,111,111 Common Stock indirectly at $18.00 ($20.0M) in a public offering. Indirect holdings up 50% to 3,333,516 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
| May 11, 2026 | Other purchase | Shelley Chu (Director) bought 11,111 Common Stock at $18.00 ($200K) in a public offering. New position of 11,111 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
| May 8, 2026 | Purchase (code P) | Jason Haas (CFO) bought 1,000 shares at $20.00 ($20K), reported as a purchase (code P). Holdings up 2% to 62,908 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
| May 8, 2026 | Purchase (code P) | Jeffrey M. Leiden (Director) bought 5,000 shares at $20.00 ($100K), reported as a purchase (code P). Holdings up 2% to 270,198 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
14 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$30.1M in purchases since May 8, 2026 · Purchases traded May 8, 2026 to May 11, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Jeffrey M. Leiden (Director) | $100K | May 8, 2026 | SEC filing |
| Jason Haas (CFO) | $20K | May 8, 2026 | SEC filing |
| Dimension Capital II, L.P. (Director) | $20.0M | May 8, 2026 | SEC filing |
| Simeon George (10% owner) | $10.0M | May 11, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ODTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.